Editing Genes and Career Paths – From Academia to Biotech to Big Pharma
Featuring Chris Borges ‘10
Wednesday, January 26, 2022 :: 12:00 noon
Emmanuel College Alumni Relations is proud to present the Emmanuel Together – Alumni Spotlight Series. This 9-part series will feature a new topic and alum profile each month September 2021-May 2022.
Please join us for a virtual lunchtime talk with Chris Borges ‘10 on the topic Editing Genes and Career Paths – From Academia to Biotech to Big Pharma.
About Chris Borges '10:
Chris completed his undergraduate in Biology at Emmanuel College, performing research in the laboratory of Megan Sykes at the Transplantation Biology Research Center at Massachusetts General Hospital along with Emmanuel faculty member Dr. Josef Kurtz. Chris completed his Ph.D. in Immunology at Harvard University, under the guidance of Dr. Laurence Turka, an expert in transplantation tolerance and regulatory T cells. Thereafter, Chris began his career in biotech at Editas Medicine, where he focused on development on CRISPR/Cas9-based gene editing in primary human T cells in the context of CAR T and NK cell projects.
During his time at Editas, Chris was the lead and corresponding author on many poster presentations and papers, as well as inventor on numerous national and international patents. Currently, Chris is a Sr. Principal Scientist and Lab Head of the Genome and Cell Engineering Lab within the Genomics Medicine Unit at Sanofi. Chris leads a team (including Emmanuel alums!) to use multiple genome engineering tools to modify the DNA of cells to enhance their function enabling improved treatment or cures for diseases ranging from Sickle Cell Disease to multiple cancers. Chris has been a member of the Emmanuel College Board of Trustees since 2016.
This registration is now closed. If you would like to attend, please email alumni@emmanuel.edu.